Daniel H Present

Daniel H Present

UNVERIFIED PROFILE

Are you Daniel H Present?   Register this Author

Register author
Daniel H Present

Daniel H Present

Publications by authors named "Daniel H Present"

Are you Daniel H Present?   Register this Author

31Publications

120Reads

-Profile Views

6-Mercaptopurine/Azathioprine remains an important contributor in managing Crohn's disease.

J Crohns Colitis 2014 Aug 22;8(8):735-8. Epub 2014 Jan 22.

ICAHN School of Medicine at Mount Sinai Hospital, New York, NY, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.crohns.2013.12.024DOI Listing
August 2014

The effect of intravenous cyclosporine on rates of colonic surgery in hospitalized patients with severe Crohn's colitis.

J Clin Gastroenterol 2012 Oct;46(9):764-7

Department of Medicine, The Harvey M. and Lyn P. Meyerhoff Inflammatory Bowel Disease Center, Division of Gastroenterology, The Johns Hopkins University Medical Institutions, Baltimore, MD 21287, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCG.0b013e31824e14a8DOI Listing
October 2012

Practice patterns in the use of anti-tumor necrosis factor alpha agents in the management of Crohn's disease: a US national practice survey comparing experts and non-experts.

Dig Dis Sci 2011 Apr 23;56(4):1160-4. Epub 2010 Dec 23.

Department of Medicine, Division of Digestive and Liver Diseases, Columbia University Medical Center, 622 West 168th Street, PH 20-303, New York, NY 10032, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s10620-010-1530
Web Search
http://link.springer.com/10.1007/s10620-010-1530-9
Publisher Site
http://dx.doi.org/10.1007/s10620-010-1530-9DOI Listing
April 2011

Cyclosporine is safe and effective in patients with severe ulcerative colitis.

J Clin Gastroenterol 2011 Feb;45(2):107-12

Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCG.0b013e3181e883ddDOI Listing
February 2011

Emerging issues in ulcerative colitis and ulcerative proctitis: individualizing treatment to maximize outcomes.

Gastroenterol Hepatol (N Y) 2009 Jun;5(6 Suppl):4-16

Stephen B. Hanauer, MD , Professor of Medicine and Clinical Pharmacology Director, Section of Gastroenterology and Nutrition University of Chicago.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886411PMC
June 2009

Screening and surveillance colonoscopy in chronic Crohn's colitis: results of a surveillance program spanning 25 years.

Clin Gastroenterol Hepatol 2008 Sep 27;6(9):993-8; quiz 953-4. Epub 2008 Jun 27.

Division of Gastroenterology, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2008.03.019DOI Listing
September 2008

Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes.

Am J Gastroenterol 2008 May 16;103(5):1203-9. Epub 2008 Apr 16.

Division of Gastroenterology, Mount Sinai Medical Center, One Gustave Levy Place, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1572-0241.2007.01756.xDOI Listing
May 2008

Adverse events associated with the use of cyclosporine in patients with inflammatory bowel disease.

Am J Gastroenterol 2008 Apr 2;103(4):937-43. Epub 2008 Jan 2.

The Dr. Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Mount Sinai Medical Center, New York, New York 10028, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1572-0241.2007.01718.xDOI Listing
April 2008

Pouch-ouch.

Curr Opin Gastroenterol 2008 Jan;24(1):70-4

Mount Sinai Medical Center, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOG.0b013e3282f2dfa3DOI Listing
January 2008

Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial.

Gastroenterology 2007 May 21;132(5):1672-83. Epub 2007 Mar 21.

Inflammatory Bowel Disease Center and Division of Gastroenterology, Cedars Sinai Medical Center, Los Angeles, California 90048, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2007.03.024DOI Listing
May 2007

Optimizing therapy in patients with pancolitis.

Inflamm Bowel Dis 2005 Oct;11(10):937-46

Johns Hopkins Hospital Division of Gastroenterology and Hepatology Baltimore, Maryland 21287, USA.

View Article

Download full-text PDF

Source
October 2005

Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease.

Inflamm Bowel Dis 2005 Mar;11(3):314-21

Division of Gastroenterology, Department of Medicine, The Mount Sinai School of Medicine, New York, New York, USA.

View Article

Download full-text PDF

Source
March 2005

Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial.

Gastroenterology 2004 Sep;127(3):723-9

Department of Medicine, University of Chicago Medical Center, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
September 2004

Maintaining remissions across the lifespan: a roundtable discussion with Crohn's disease experts.

Inflamm Bowel Dis 2004 Jul;10 Suppl 2:S11-21

University of Pennsylvania School of Medicine, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
July 2004

Crohn's is not a 6-week disease: lifelong management of mild to moderate Crohn's disease.

Inflamm Bowel Dis 2004 Jul;10 Suppl 2:S2-10

University of Pennsylvania School of Medicine, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
July 2004

Medical management of the pregnant patient with inflammatory bowel disease.

Gastroenterol Clin North Am 2004 Jun;33(2):361-85, xi

Mount Sinai School of Medicine, Mount Sinai Hospital, 12 East 86th Street, New York, NY 10028, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gtc.2004.02.013DOI Listing
June 2004

6-Mercaptopurine is effective in Crohn's disease without concomitant steroids.

Inflamm Bowel Dis 2004 Mar;10(2):79-84

Department of Medicine, Division of Gastroenterology, Mount Sinai School of Medicine, USA.

View Article

Download full-text PDF

Source
March 2004

The state of the art in the management of inflammatory bowel disease.

Rev Gastroenterol Disord 2003 ;3(2):81-92

Section of Gastroenterology and Nutrition, University of Chicago, Pritzker School of Medicine, Chicago, IL, USA.

View Article

Download full-text PDF

Source
June 2003

Crohn's fistula: current concepts in management.

Authors:
Daniel H Present

Gastroenterology 2003 May;124(6):1629-35

Mount Sinai School of Medicine, New York, New York 10028-0517, USA.

View Article

Download full-text PDF

Source
May 2003

The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study.

Gastroenterology 2003 Jan;124(1):9-17

Department of Medicine and Biostatistics, Mount Sinai Hospital Medical Center, 12 East 86th Street, New York, NY 10028, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/gast.2003.50014DOI Listing
January 2003

Urinary tract fistulas in Crohn's disease: surgery versus medical therapy.

Authors:
Daniel H Present

Am J Gastroenterol 2002 Sep;97(9):2165-7

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1572-0241.2002.05967.xDOI Listing
September 2002

Serologic tests are not helpful in managing inflammatory bowel disease.

Authors:
Daniel H Present

Inflamm Bowel Dis 2002 May;8(3):227-9; discussion 223, 230-1

Department of Medicine, Division of Gastroenterology, Mount Sinai Medical Center, New York, New York, USA.

View Article

Download full-text PDF

Source
May 2002